ClinicalTrials.gg
CompletedNCT06895382Updated Apr 1, 2025

Caudal Epidural Vs. TAP Block for Postoperative Analgesia in Pediatric Infraumbilical Surgery: a RCT

An interventional study of Caudal Epidural Block and Transversus Abdominis Plane (TAP) Block in Postoperative Pain, Pediatric Surgery and Anesthesia, Local, sponsored by Namik Kemal University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 1 Year to 7 Years. Per ClinicalTrials.gov, last updated 2025-04-01.

Sponsored by Namik Kemal University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 3 months after the study started (first participant enrolled Dec 2022, registered Mar 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
1 Year to 7 Years
Sex
All
01

Study summary

This randomized controlled trial investigates the postoperative analgesic efficacy of caudal epidural block versus ultrasound-guided transversus abdominis plane (TAP) block in pediatric patients undergoing infraumbilical surgery.

A total of 60 pediatric patients (aged 1 to 7 years, ASA I-II) were randomly assigned to one of two groups:

  • Group C (Caudal Block): Received 1 mL/kg of 0.25% bupivacaine in the caudal epidural space.
  • Group T (TAP Block): Received 0.3 mL/kg of 0.25% bupivacaine injected into the transversus abdominis plane under ultrasound guidance.

Primary Outcome:

  • Postoperative FLACC pain scores at 2, 6, 12, and 24 hours.

Secondary Outcomes:

  • Total analgesic consumption (including rescue analgesia).
  • Intraoperative hemodynamic parameters (heart rate, blood pressure, SpO₂).
  • Incidence of nausea and vomiting (PONV).
  • Parental satisfaction scores.

The study aims to determine which regional anesthesia technique provides superior pain relief and reduces systemic analgesic requirements in pediatric patients.

Read the detailed description

Postoperative pain management in pediatric patients is a challenge due to difficulties in pain assessment and concerns about opioid-related adverse effects. While caudal epidural block has traditionally been the standard of care for infraumbilical pediatric surgeries, ultrasound-guided transversus abdominis plane (TAP) block has emerged as a promising alternative with the potential for longer-lasting analgesia and fewer motor block complications.

This randomized controlled trial was conducted at Tekirdağ Namık Kemal University Hospital between December 2022 and December 2023. A total of 60 pediatric patients (aged 1-7 years, ASA I-II) undergoing infraumbilical surgery were enrolled and randomly assigned to receive either:

  • Caudal epidural block (1 mL/kg of 0.25% bupivacaine via the sacral hiatus).
  • TAP block (0.3 mL/kg of 0.25% bupivacaine in the fascial plane between the internal oblique and transversus abdominis muscles under ultrasound guidance).

General anesthesia was induced using sevoflurane inhalation, followed by propofol (2-3 mg/kg) and fentanyl (1 µg/kg) for IV induction. A laryngeal mask airway (LMA) was used, and anesthesia was maintained with sevoflurane at a MAC of 1.0%.

Outcome Measures:

  • Primary Outcome:

    • FLACC pain scores at 2, 6, 12, and 24 hours postoperatively.
  • Secondary Outcomes:

    • Total postoperative analgesic consumption (including rescue analgesia).
    • Hemodynamic parameters (HR, SBP, DBP, SpO₂) recorded at predefined intraoperative time points.
    • Incidence of postoperative nausea and vomiting (PONV).
    • Parental satisfaction scores collected post-discharge.

Statistical Analysis:

Data were analyzed using SPSS 25.0. Sample size was determined using G*Power 3.1.9.2, with an effect size (d) of 0.75, power of 0.80, and Type I error of 0.05. The study followed randomized allocation with blinding of pain assessors.

This study aims to determine whether TAP block provides equivalent or superior analgesia compared to caudal epidural block in pediatric patients undergoing infraumbilical surgeries. Findings will help guide future pediatric regional anesthesia protocols.

02

Conditions studied

  • Postoperative Pain
  • Pediatric Surgery
  • Anesthesia, Local
  • Regional Anesthesia
  • Abdominal Surgery

Browse trials for

Keywords

  • Caudal Epidural Block
  • Transversus Abdominis Plane Block
  • Pediatric Pain Management
03

In context

Pain, Postoperative

5,227 studies on the registry are indexed under Pain, Postoperative; 1,154 are open to participants now.

This study's enrollment of 60 is below the median of 75 across 4,457 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Namik Kemal University is the lead sponsor of 59 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 7 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pediatric patients aged 1 to 7 years.
  • ASA Physical Status I-II.
  • Undergoing infraumbilical abdominal surgery (e.g., hernia repair, orchiopexy, circumcision).
  • Parental written informed consent obtained.

Exclusion criteria

Exclusion Criteria:

  • Contraindications to regional anesthesia, such as:
  • Coagulopathy or bleeding disorders.
  • Local infection at the injection site.
  • Known allergy to local anesthetics.
  • Neurological conditions (e.g., degenerative neuropathy, brain tumors, increased intracranial pressure).
  • Intellectual disabilities affecting pain assessment.
  • Chronic pain conditions or opioid use before surgery.
  • Parental refusal to participate in the study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Group C - Caudal Epidural Block

    Participants in this group received a caudal epidural block after the induction of general anesthesia. A 35-mm 22G or 30-mm 25G block needle was inserted through the sacrococcygeal ligament into the epidural space under aseptic conditions. After confirming negative aspiration for cerebrospinal fluid or blood, 1 mL/kg of 0.25% bupivacaine was administered.

    Procedure: Caudal Epidural Block · Drug: Bupivacaine 0.25%

  • Experimental
    Group T - Transversus Abdominis Plane (TAP) Block

    Participants in this group received an ultrasound-guided transversus abdominis plane (TAP) block after the induction of general anesthesia. A 22G, 50-mm insulated block needle was inserted using an in-plane technique under ultrasound guidance with a linear probe. The needle was advanced into the fascial plane between the internal oblique and transversus abdominis muscles. After confirming placement with a 0.5-1 mL test dose of 0.9% NaCl and negative aspiration for blood, 0.3 mL/kg of 0.25% bupivacaine was administered.

    Procedure: Transversus Abdominis Plane (TAP) Block · Drug: Bupivacaine 0.25%

Interventions

  • ProcedureCaudal Epidural Block

    A caudal epidural block was performed after the induction of general anesthesia. Using a 35-mm 22G or 30-mm 25G block needle, the sacral hiatus was identified, and the needle was inserted through the sacrococcygeal ligament into the epidural space under aseptic conditions. After confirming negative aspiration for cerebrospinal fluid or blood, 1 mL/kg of 0.25% bupivacaine was administered.

    Also known as: Caudal Block, Caudal Anesthesia

  • ProcedureTransversus Abdominis Plane (TAP) Block

    A transversus abdominis plane (TAP) block was performed after the induction of general anesthesia. Using a 22G, 50-mm insulated block needle, the injection was administered under ultrasound guidance using a linear probe and in-plane technique. The needle was advanced into the fascial plane between the internal oblique and transversus abdominis muscles. After confirming placement with a 0.5-1 mL test dose of 0.9% NaCl and negative aspiration for blood, 0.3 mL/kg of 0.25% bupivacaine was administered.

    Also known as: TAP Block, Ultrasound-Guided TAP Block

  • 0.25% bupivacaine was administered in both intervention arms as part of the regional anesthesia procedure In the Caudal Block group, 1 mL/kg of 0.25% bupivacaine was administered into the caudal epidural space. In the TAP Block group, 0.3 mL/kg of 0.25% bupivacaine was administered into the transversus abdominis plane under ultrasound guidance

06

What researchers measure

Primary outcomes

  1. Postoperative FLACC Pain Scores

    Postoperative pain intensity was measured using the Face, Legs, Activity, Cry, Consolability (FLACC) scale at predefined time points after surgery. The FLACC scale is a validated tool for assessing postoperative pain in pediatric patients based on behavioral observations.

    Time frame: FLACC pain scores were recorded at 2, 6, 12, and 24 hours postoperatively

Secondary outcomes

  1. Total Postoperative Analgesic Consumption

    The total amount of rescue analgesia (paracetamol, NSAIDs, opioids) administered in the first 24 hours postoperatively was recorded. This includes any additional medication given based on the patient's pain score.

    Time frame: 0-24 hours postoperatively

  2. Intraoperative Hemodynamic Stability

    Heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), and arterial oxygen saturation (SpO₂) were recorded at predefined intraoperative time points to assess the hemodynamic effects of the regional anesthesia techniques.

    Time frame: Baseline, after induction, after surgical incision, and at 15, 30, 45, and 60 minutes intraoperatively.

  3. Incidence of Postoperative Nausea and Vomiting (PONV)

    The number of patients experiencing postoperative nausea and vomiting (PONV) within the first 24 hours was recorded.

    Time frame: 0-24 hours postoperatively

  4. Parental Satisfaction Scores

    Parental satisfaction with their child's postoperative pain management was assessed using a 5-point Likert scale, ranging from 1 (very dissatisfied) to 5 (very satisfied).

    Time frame: Recorded at 24 hours postoperatively and at a follow-up phone call after discharge.

07

Study locations

1 site
  • Tekirdag Namik Kemal University
    Tekirdağ, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06895382
Lead sponsor
Namik Kemal University
Responsible party
Onur Baran (Principal Investigator, Namik Kemal University) — Principal investigator
First posted
Mar 26, 2025
Start date
Dec 15, 2022
Primary completion
Dec 15, 2023
Completion
Dec 15, 2023
Last update
Apr 1, 2025

Study contacts

Onur Baran
study chair · Namik Kemal University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion